Our team was founded by world-leading transplant surgeons who have witnessed firsthand the power of organ transplantation to save and transform lives. Yet every day, we also see the profound limitations of today’s standard of care. To prevent rejection, patients must rely on life-long immunosuppression—a regimen of powerful drugs that weakens the immune system, leaving patients vulnerable to infection, cancer, and other serious complications. Over time, these same medications can even damage or destroy the very organ they were meant to protect.
Despite decades of medical progress, this dependence on immunosuppression remains one of transplantation’s greatest unsolved challenges.
We believe it’s time for a new approach—one that enables true immune tolerance and lasting transplant health without life-long toxicity.
Our mission is to restore immune harmony — enabling patients to receive lifesaving organ and cell transplants without chronic drugs. Through cutting-edge hematopoietic stem-cell technologies, we aim to induce durable immune tolerance and establish the foundation for a new class of curative therapies in transplantation, while facilitating translational regenerative and stem cell based research across medicine.